Onconetix, Inc. Gain (Loss) on Termination of Lease
Onconetix, Inc. (ONCO) had Gain (Loss) on Termination of Lease of $302.34 thousand as of 2025-09-24, per its 10-K filed 2026-03-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-03-13
- 2025-09-24: Gain (Loss) on Termination of Lease $302.34K.
| Period end | Gain (Loss) on Termination of Lease |
|---|---|
| 2025-09-24 | $302.34K 10-K · filed 2026-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |